Abstract: The invention relates to an orally administrable chewable composition in unit dosage form comprising an oil-in-water emulsion in which the aqueous phase is gelled and in which the oil phase comprises a physiologically tolerable unsaturated fatty acid ester.
Abstract: The invention provides an oral pharmaceutical composition, optionally in dose unit form, comprising a lipophilic drug substance in dispersion in a physiologically tolerable aqueous carrier, preferably an aqueous gel, wherein said drug substance contains a functional electrostatic group having a pKa value of from 2 to 10, characterised in that said aqueous carrier has a pH at least 0.3 below or above said pKa value, said pH being below said pKa where said group is acidic and above said pKa where said group is basic.
Type:
Grant
Filed:
October 19, 2011
Date of Patent:
April 6, 2021
Assignee:
VITUX GROUP AS
Inventors:
Kurt Ingar Draget, Steinar Johan Engelsen, Tore Seternes, Magnus Hattrem, Ingvild Johanne Haug
Abstract: An oral pharmaceutical composition in unit dose form, each unit dose comprising a lipophilic drug substance within a unitary carrier body, said body comprising a soft, chewable, gelled oil-in-water emulsion.
Type:
Grant
Filed:
June 30, 2017
Date of Patent:
June 2, 2020
Assignee:
VITUX GROUP AS
Inventors:
Tore Seternes, Kurt Ingar Draget, Ingvild Johanne Haug
Abstract: This invention provides an oral veterinary pharmaceutical or nutraceutical composition comprising a physiologically tolerable gelled oil-in-water emulsion further comprising at least one component selected from taste enhancers, odour enhancers, digestive enzymes and veterinary drugs.
Type:
Application
Filed:
May 20, 2019
Publication date:
September 5, 2019
Applicant:
VITUX GROUP AS
Inventors:
Kurt Ingar DRAGET, Ingvild Johanne HAUG, Steinar Johan ENGELSEN, Tore SETERNES
Abstract: The invention relates to an orally administrable chewable composition in unit dosage form comprising an oil-in-water emulsion in which the aqueous phase is gelled and in which the oil phase comprises a physiologically tolerable unsaturated fatty acid ester.
Abstract: An oral pharmaceutical composition in unit dose form, each unit dose comprising a lipophilic drug substance within a unitary carrier body, said body comprising a soft, chewable, gelled oil-in-water emulsion.
Type:
Application
Filed:
June 30, 2017
Publication date:
October 19, 2017
Applicant:
VITUX GROUP AS
Inventors:
Tore SETERNES, Kurt Ingar DRAGET, Ingvild Johanne HAUG
Abstract: An oral pharmaceutical composition in unit dose form, each unit dose comprising a lipophilic drug substance within a unitary carrier body, said body comprising a soft, chewable, gelled oil-in-water emulsion.
Type:
Grant
Filed:
October 15, 2014
Date of Patent:
August 8, 2017
Assignee:
VITUX GROUP AS
Inventors:
Tore Seternes, Kurt Ingar Draget, Ingvild Johanne Haug